Class Action and Product Insights for Your Business
April 30, 2020 - Coronavirus (COVID-19), FDA, Pharmaceutical & Medical Devices

Mental Health During COVID-19: FDA Waivers for Digital Health Devices

Using Waivers to Curb COVID-19 Legal Exposure

As the number of days during which the U.S. remains under stay-at-home orders increases, the mental health of individuals has become a growing concern.  Last week, the U.S. Food and Drug Administration (FDA) announced temporarily waiving certain requirements for digital health devices for treating psychiatric disorders in its Enforcement Policy for Digital Health Devices for Treating Psychiatric Disorders During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (“the Guidance”).

Read more on MoFo Life Sciences.